Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer
Clinical trial NCT02639234 · WITHDRAWN
Trial details
- NCT number
- NCT02639234
- Sponsor
- Gradalis, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-03-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.